Insulin secretion in pancreatic islets from rats with cirrhosis

Jian Wu, Per Lindström, Åke Danielsson, Janove Sehlin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cirrhosis was induced in rats by subcutaneous injections of CCl4 for 13 or 17 weeks. The morphology of the pancreatic islets from the CCl4-treated rats was found to be normal. The CCl4-treated rats had lower fasting serum glucose levels and higher serum insulin levels than the controls. After an oral glucose load (3 g/kg body weight), glucose levels in CCl4-treated rats stayed within the normal range, whereas the serum insulin levels remained higher with a delayed decline of insulin with time. In vitro perifusion of islets from the CCl4-treated rats showed that the response to 16.7 mmol/l glucose was reduced with both lower total insulin output and stimulated insulin output, whereas the patterns of first and second phase of insulin release did not differ. The insulin content of the perifused islets was not affected by 13 weeks of CCl4 treatment. Islets from rats treated with CCl4 for 17 weeks showed normal secretory response to 20 mmol/l L-arginine. Taken together, the results, showing normal or reduced capacity for insulin secretion, suggest that the hyperinsulinemia accompanying CCl4-induced cirrhosis is not due to increased secretion of the pancreatic islets. It may rather be associated with decreased insulin degradation by the liver with cirrhosis.

Original languageEnglish (US)
Pages (from-to)332-339
Number of pages8
JournalJournal of Hepatology
Volume21
Issue number3
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Islets of Langerhans
Fibrosis
Insulin
Glucose
Serum
Hyperinsulinism
Subcutaneous Injections
Liver Cirrhosis
Arginine
Fasting
Reference Values
Body Weight

Keywords

  • CCl
  • Cirrhosis
  • Glucose homeostasis
  • Rat

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Insulin secretion in pancreatic islets from rats with cirrhosis. / Wu, Jian; Lindström, Per; Danielsson, Åke; Sehlin, Janove.

In: Journal of Hepatology, Vol. 21, No. 3, 1994, p. 332-339.

Research output: Contribution to journalArticle

Wu, J, Lindström, P, Danielsson, Å & Sehlin, J 1994, 'Insulin secretion in pancreatic islets from rats with cirrhosis', Journal of Hepatology, vol. 21, no. 3, pp. 332-339. https://doi.org/10.1016/S0168-8278(05)80310-1
Wu, Jian ; Lindström, Per ; Danielsson, Åke ; Sehlin, Janove. / Insulin secretion in pancreatic islets from rats with cirrhosis. In: Journal of Hepatology. 1994 ; Vol. 21, No. 3. pp. 332-339.
@article{87019ae96b6845b8b17df5e6c9aeef6c,
title = "Insulin secretion in pancreatic islets from rats with cirrhosis",
abstract = "Cirrhosis was induced in rats by subcutaneous injections of CCl4 for 13 or 17 weeks. The morphology of the pancreatic islets from the CCl4-treated rats was found to be normal. The CCl4-treated rats had lower fasting serum glucose levels and higher serum insulin levels than the controls. After an oral glucose load (3 g/kg body weight), glucose levels in CCl4-treated rats stayed within the normal range, whereas the serum insulin levels remained higher with a delayed decline of insulin with time. In vitro perifusion of islets from the CCl4-treated rats showed that the response to 16.7 mmol/l glucose was reduced with both lower total insulin output and stimulated insulin output, whereas the patterns of first and second phase of insulin release did not differ. The insulin content of the perifused islets was not affected by 13 weeks of CCl4 treatment. Islets from rats treated with CCl4 for 17 weeks showed normal secretory response to 20 mmol/l L-arginine. Taken together, the results, showing normal or reduced capacity for insulin secretion, suggest that the hyperinsulinemia accompanying CCl4-induced cirrhosis is not due to increased secretion of the pancreatic islets. It may rather be associated with decreased insulin degradation by the liver with cirrhosis.",
keywords = "CCl, Cirrhosis, Glucose homeostasis, Rat",
author = "Jian Wu and Per Lindstr{\"o}m and {\AA}ke Danielsson and Janove Sehlin",
year = "1994",
doi = "10.1016/S0168-8278(05)80310-1",
language = "English (US)",
volume = "21",
pages = "332--339",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Insulin secretion in pancreatic islets from rats with cirrhosis

AU - Wu, Jian

AU - Lindström, Per

AU - Danielsson, Åke

AU - Sehlin, Janove

PY - 1994

Y1 - 1994

N2 - Cirrhosis was induced in rats by subcutaneous injections of CCl4 for 13 or 17 weeks. The morphology of the pancreatic islets from the CCl4-treated rats was found to be normal. The CCl4-treated rats had lower fasting serum glucose levels and higher serum insulin levels than the controls. After an oral glucose load (3 g/kg body weight), glucose levels in CCl4-treated rats stayed within the normal range, whereas the serum insulin levels remained higher with a delayed decline of insulin with time. In vitro perifusion of islets from the CCl4-treated rats showed that the response to 16.7 mmol/l glucose was reduced with both lower total insulin output and stimulated insulin output, whereas the patterns of first and second phase of insulin release did not differ. The insulin content of the perifused islets was not affected by 13 weeks of CCl4 treatment. Islets from rats treated with CCl4 for 17 weeks showed normal secretory response to 20 mmol/l L-arginine. Taken together, the results, showing normal or reduced capacity for insulin secretion, suggest that the hyperinsulinemia accompanying CCl4-induced cirrhosis is not due to increased secretion of the pancreatic islets. It may rather be associated with decreased insulin degradation by the liver with cirrhosis.

AB - Cirrhosis was induced in rats by subcutaneous injections of CCl4 for 13 or 17 weeks. The morphology of the pancreatic islets from the CCl4-treated rats was found to be normal. The CCl4-treated rats had lower fasting serum glucose levels and higher serum insulin levels than the controls. After an oral glucose load (3 g/kg body weight), glucose levels in CCl4-treated rats stayed within the normal range, whereas the serum insulin levels remained higher with a delayed decline of insulin with time. In vitro perifusion of islets from the CCl4-treated rats showed that the response to 16.7 mmol/l glucose was reduced with both lower total insulin output and stimulated insulin output, whereas the patterns of first and second phase of insulin release did not differ. The insulin content of the perifused islets was not affected by 13 weeks of CCl4 treatment. Islets from rats treated with CCl4 for 17 weeks showed normal secretory response to 20 mmol/l L-arginine. Taken together, the results, showing normal or reduced capacity for insulin secretion, suggest that the hyperinsulinemia accompanying CCl4-induced cirrhosis is not due to increased secretion of the pancreatic islets. It may rather be associated with decreased insulin degradation by the liver with cirrhosis.

KW - CCl

KW - Cirrhosis

KW - Glucose homeostasis

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0028031287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028031287&partnerID=8YFLogxK

U2 - 10.1016/S0168-8278(05)80310-1

DO - 10.1016/S0168-8278(05)80310-1

M3 - Article

C2 - 7836701

AN - SCOPUS:0028031287

VL - 21

SP - 332

EP - 339

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 3

ER -